Status: current, Defined. Date: 31-Oct 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1457991000168119 | carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL intestinal gel (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1458001000168111 | levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | Is a | levodopa + carbidopa | true | Inferred relationship | Some | ||
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | has intended active ingredient | levodopa | true | Inferred relationship | Some | 74393116 | |
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | has Australian BoSS | levodopa | true | Inferred relationship | Some | 74393116 | |
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | has intended active ingredient | carbidopa | true | Inferred relationship | Some | 1679371842 | |
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | has Australian BoSS | carbidopa monohydrate | true | Inferred relationship | Some | 1679371842 | |
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | has manufactured dose form | intestinal gel | true | Inferred relationship | Some | ||
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | has unit of use | continuous | true | Inferred relationship | Some | 1679371843 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Duodopa (carbidopa monohydrate 5 mg / 1 mL + levodopa 20 mg / 1 mL) intestinal gel (trade product unit of use) | Is a | True | levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | Inferred relationship | Some | |
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 100 mL | has MPUU | True | levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | Inferred relationship | Some | 1 |
| levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel, 7 x 100 mL | has MPUU | True | levodopa 20 mg/mL + carbidopa monohydrate 5 mg/mL intestinal gel | Inferred relationship | Some | 2 |
Reference Sets
Medicinal product unit of use reference set